Author:
Clark Mervin L.,Rudy Ramsey H.,Ragland Robert E.,Rahhal Don K.,Serafetinides Eustace A.,Paul Costiloe J.
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Ayd, F.: Large doses of chlorpromazine in the treatment of psychiatric patients. Dis. nerv. Syst. 16, 146?149 (1955).
2. Brotman, R. K., Muzekari, L. H., Shauken, P. M.: Butaperazine in chronic schizophrenic patients. A double-blind study. Curr. ther. Res. 11, 5?8 (1969).
3. Clark, M. L., Ray, T. S., Paredes, A., Costiloe, J. P., Chappell, J. S., Hagans, J. A., Wolf, S.: Chlorpromazine in chronic schizophrenic women: Experimental design and effects at maximum point of treatment. Psychopharmacologia (Berl.) 2, 107?137 (1961).
4. Cochran, W. G.: Analysis of covariance. Its nature and use. Biometrics 13, 261 to 281 (1957).
5. Forrest, F. M., Geiter, C. W., Snow, H. L., Steinbach, M.: Drug maintenance problems of rehabilitated mental patients: The current drug-dosage ?merry-go-round?. Amer. J. Psychiat. 121, 33?40 (1964).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of phenothiazine compounds on the secondary structure and fibrillogenesis of poly-l-lysine;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2019-06
2. Schizophrenia;PharmacotherapyFirst: A Multimedia Learning Resource;2017-05
3. Chlorpromazine dose for people with schizophrenia;Cochrane Database of Systematic Reviews;2017-04-13
4. Placebo Response in Antipsychotic Clinical Trials;JAMA Psychiatry;2014-12-01
5. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2014-01-06